OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk
Titel:
OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk
Auteur:
Tute, Ruth De Pawlyn, Charlotte Cairns, David Davies, Faith Rawstron, Andy Jones, John Hockaday, Anna Menzies, Tom Henderson, Rowena Cook, Gordon Drayson, Mark Jenner, Matthew Kaiser, Martin Gregory, Walter Morgan, Gareth Jackson, Graham Owen, Roger